INNOVATION PHARMACEUTICALS INC. Income (Loss) from Continuing Operations, Per Basic Share
INNOVATION PHARMACEUTICALS INC. reported Income (Loss) from Continuing Operations, Per Basic Share of $0.00 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2021-11-09
- INNOVATION PHARMACEUTICALS INC. income (loss) from continuing operations, per basic share for the quarter ending 2021-09-30 was $0.00.
- INNOVATION PHARMACEUTICALS INC. income (loss) from continuing operations, per basic share for the quarter ending 2020-09-30 was $0.00.
- INNOVATION PHARMACEUTICALS INC. income (loss) from continuing operations, per basic share for fiscal 2021 was -$0.04.
- INNOVATION PHARMACEUTICALS INC. income (loss) from continuing operations, per basic share for fiscal 2020 was -$0.03.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$0.04 10-K · filed 2021-09-27 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.03 10-K · filed 2021-09-27 |